Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 4NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Rhabdomyosarcoma 1Melanoma 1

Interventions

Specimen Handling 7Magnetic Resonance Spectroscopy 7Radiotherapy 5Biopsy 4Radiation 3High-Energy Shock Waves 3Cyclophosphamide 3venetoclax 2X-Rays 2Vincristine 2Spinal Puncture 2Sentinel Lymph Node Biopsy 2Radiosurgery 2Paclitaxel 2Daunorubicin 2Cytarabine 2Azacitidine 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1taxane 1sulforaphane 1sacituzumab govitecan 1revumenib 1prednylidene 1pertuzumab 1pembrolizumab 1pegaspargase 1nelarabine 1merphos 1liposomal doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × NETWORK × Sentinel Lymph Node Biopsy × Clear all
NCT07621614 2026-06-05

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

Children's Oncology Group

Phase NA Not yet recruiting
51 enrolled
Dermatologic

Melanoma

NCT07466316 2026-03-12

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

Children's Oncology Group

Phase 3 Not yet recruiting
342 enrolled
Sarcoma

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡